913388-48-4

Basic information

• Product Name: 1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-diMethylethyl ester
• Synonyms: 1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-diMethylethyl ester;tert-Butyl 5-(4-methylpiperazin-1-yl)-1H-indole-1-carboxylate
• CAS NO: 913388-48-4
• Molecular Formula: C18H25N3O2
• Molecular Weight: 315.41
• Mol File: 913388-48-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-diMethylethyl ester(913388-48-4)
• EPA Substance Registry System: 1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-diMethylethyl ester(913388-48-4)

Safety Data

• Hazardous Substances Data: 913388-48-4(Hazardous Substances Data)

Usage

General Description

1H-Indole-1-carboxylic acid, 5-(4-Methyl-1-piperazinyl)-, 1,1-dimethylethyl ester is a chemical compound with a complex structure that contains several functional groups. It falls under the overarching category of organic chemicals, specifically indoles, which are a type of heterocyclic compound. This specific compound has a substituted indole ring with a carboxylic acid ester group and a 4-methylpiperazine moiety attached. The presence of methyl and piperazine groups suggest the compound exhibits pharmacological properties; however, detailed characteristics, such as its physical state, color, experimental or predicted properties like boiling point, melting point, density, safety hazards, or biological activities are not typically available in public databases unless specifically studied and recorded.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 109-01-3 1-methyl-piperazine 
• 374818-66-3 tert-butyl 5-iodo-1H-indole-1-carboxylate 

Relevant articles and documents

JAK INHIBITOR

A JAK inhibitor comprising, as an active ingredient, a nitrogen-containing heterocyclic compound represented by formula (I) {wherein W represents a nitrogen atom or -CH-; X represents -C (=O) - or -CHR4- (wherein R4 represents a hydrogen atom, or the like); R1 represents the formula described below [wherein Q1 represents-CR8-(wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); Q2 represents -NR15- (wherein R15 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like); and R5 and R6 may be the same or different and each represents a hydrogen atom, halogen, carboxy, substituted or unsubstituted lower alkyl, or the like], or the like; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof.